cuprizone has been researched along with ginsenoside rg1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, X; Guo, Y; Li, M; Li, Q; Li, Y; Liu, L; Liu, Q; Ran, Q; Sun, L; Yang, L; Yang, Q; Zhu, X | 1 |
1 other study(ies) available for cuprizone and ginsenoside rg1
| Article | Year |
|---|---|
Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
Topics: Animals; beta Catenin; Cell Differentiation; Cuprizone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Ginsenosides; Glycogen Synthase Kinase 3 beta; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendrocyte Precursor Cells; Remyelination | 2022 |